0517578 - FGÚ 2020 RIV GB eng J - Journal Article
Pokorná, Z. - Jirkovský, E. - Hlaváčková, Markéta - Jansová, H. - Jirkovská, A. - Lencová-Popelová, O. - Brázdová, P. - Kubeš, J. - Sotáková-Kašparová, Dita - Mazurová, Y. - Adamcová, M. - Vostatková, L. - Holzerová, Kristýna - Kolář, František - Šimůnek, T. - Štěrba, M.
In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline.
Clinical science. Roč. 133, č. 16 (2019), s. 1827-1844. ISSN 0143-5221. E-ISSN 1470-8736
R&D Projects: GA ČR(CZ) GA13-15008S
Institutional support: RVO:67985823
Keywords : anthracyclines * bortezomib * carfilzomib * cardiotoxicity * proteasome inhibitors
OECD category: Pharmacology and pharmacy
Impact factor: 5.223, year: 2019 ; AIS: 1.327, rok: 2019
Method of publishing: Limited access
Result website:
https://doi.org/10.1042/CS20190139DOI: https://doi.org/10.1042/CS20190139
Permanent Link: http://hdl.handle.net/11104/0302904